Full Breakdown
Trial Treatment Offers Relief for Hereditary Angioedema Patient
8/23/2026, 9:28:48 PM
Patient Experience with New HAE Treatment
Jack Cope, a 30-year-old joiner from Bedford, has lived with hereditary angioedema (HAE) since birth. The disorder causes unpredictable swelling in the throat, stomach, face and extremities, and even routine tasks such as using a hammer can trigger painful attacks. Prior to enrolling in a clinical trial, Cope experienced roughly one swelling episode per week. After joining the trial at Addenbrooke’s Hospital in Cambridge, he reports that attacks have ceased for nearly a year.
Background on Hereditary Angioedema
HAE is a rare genetic condition characterized by sudden, severe swelling episodes that can threaten the airway and impair daily activities. Swelling can affect any body part and is often precipitated by physical trauma, stress or certain medications. Because attacks are unpredictable, individuals with HAE frequently face limitations in work and personal life.
Trial at Addenbrooke’s Hospital
Addenbrooke’s Hospital is conducting a trial of a novel therapy aimed at reducing the frequency and severity of HAE attacks. Participants, including Cope, receive the investigational treatment under medical supervision. According to Cope’s account, the therapy has “massively reduced” his symptoms, shifting his experience from weekly attacks to none over an extended period. The trial’s broader outcomes have not been detailed in the available source.
Verbatim Quote
“It's changed my life. I can do everything I want to now. It's brilliant,” — Jack Cope. The
